Literature DB >> 28794432

TDP-43 stabilises the processing intermediates of mitochondrial transcripts.

Keiichi Izumikawa1,2, Yuko Nobe2,3, Harunori Yoshikawa1,2,4, Hideaki Ishikawa1,2, Yutaka Miura1, Hiroshi Nakayama5, Takashi Nonaka6, Masato Hasegawa6, Naohiro Egawa7, Haruhisa Inoue7, Kouki Nishikawa8, Koji Yamano9, Richard J Simpson1,10, Masato Taoka2,3, Yoshio Yamauchi2,3, Toshiaki Isobe2,3, Nobuhiro Takahashi11,12.   

Abstract

The 43-kDa trans-activating response region DNA-binding protein 43 (TDP-43) is a product of a causative gene for amyotrophic lateral sclerosis (ALS). Despite of accumulating evidence that mitochondrial dysfunction underlies the pathogenesis of TDP-43-related ALS, the roles of wild-type TDP-43 in mitochondria are unknown. Here, we show that the small TDP-43 population present in mitochondria binds directly to a subset of mitochondrial tRNAs and precursor RNA encoded in L-strand mtDNA. Upregulated expression of TDP-43 stabilised the processing intermediates of mitochondrial polycistronic transcripts and their products including the components of electron transport and 16S mt-rRNA, similar to the phenotype observed in cells deficient for mitochondrial RNase P. Conversely, TDP-43 deficiency reduced the population of processing intermediates and impaired mitochondrial function. We propose that TDP-43 has a novel role in maintaining mitochondrial homeostasis by regulating the processing of mitochondrial transcripts.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28794432      PMCID: PMC5550480          DOI: 10.1038/s41598-017-06953-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  41 in total

1.  Hierarchical RNA Processing Is Required for Mitochondrial Ribosome Assembly.

Authors:  Oliver Rackham; Jakob D Busch; Stanka Matic; Stefan J Siira; Irina Kuznetsova; Ilian Atanassov; Judith A Ermer; Anne-Marie J Shearwood; Tara R Richman; James B Stewart; Arnaud Mourier; Dusanka Milenkovic; Nils-Göran Larsson; Aleksandra Filipovska
Journal:  Cell Rep       Date:  2016-08-04       Impact factor: 9.423

2.  Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy.

Authors:  Nicole F Liachko; Chris R Guthrie; Brian C Kraemer
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

Review 3.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

4.  TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.

Authors:  Hans Wils; Gernot Kleinberger; Jonathan Janssens; Sandra Pereson; Geert Joris; Ivy Cuijt; Veerle Smits; Chantal Ceuterick-de Groote; Christine Van Broeckhoven; Samir Kumar-Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-03       Impact factor: 11.205

5.  Characterizing the RNA targets and position-dependent splicing regulation by TDP-43.

Authors:  James R Tollervey; Tomaž Curk; Boris Rogelj; Michael Briese; Matteo Cereda; Melis Kayikci; Julian König; Tibor Hortobágyi; Agnes L Nishimura; Vera Zupunski; Rickie Patani; Siddharthan Chandran; Gregor Rot; Blaž Zupan; Christopher E Shaw; Jernej Ule
Journal:  Nat Neurosci       Date:  2011-02-27       Impact factor: 24.884

6.  Full-length TDP-43 and its C-terminal fragments activate mitophagy in NSC34 cell line.

Authors:  Kun Hong; Yi Li; Weisong Duan; Yansu Guo; Hong Jiang; Wenju Li; Chunyan Li
Journal:  Neurosci Lett       Date:  2012-10-09       Impact factor: 3.046

7.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

8.  Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.

Authors:  E Buratti; F E Baralle
Journal:  J Biol Chem       Date:  2001-07-24       Impact factor: 5.157

9.  Structural determinants of the cellular localization and shuttling of TDP-43.

Authors:  Youhna M Ayala; Paola Zago; Andrea D'Ambrogio; Ya-Fei Xu; Leonard Petrucelli; Emanuele Buratti; Francisco E Baralle
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

10.  Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life.

Authors:  James A Austin; Gareth S A Wright; Seiji Watanabe; J Günter Grossmann; Svetlana V Antonyuk; Koji Yamanaka; S Samar Hasnain
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

View more
  23 in total

Review 1.  TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.

Authors:  Ju Gao; Luwen Wang; Tingxiang Yan; George Perry; Xinglong Wang
Journal:  Mol Cell Neurosci       Date:  2019-08-21       Impact factor: 4.314

2.  Cytoplasmic mislocalization and mitochondrial colocalization of TDP-43 are common features between normal aged and young mice.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Ju Gao; Luwen Wang; Jingjing Liang; Xinglong Wang
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-25

3.  Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis.

Authors:  Arpan R Mehta; Jenna M Gregory; Owen Dando; Roderick N Carter; Karen Burr; Jyoti Nanda; David Story; Karina McDade; Colin Smith; Nicholas M Morton; Don J Mahad; Giles E Hardingham; Siddharthan Chandran; Bhuvaneish T Selvaraj
Journal:  Acta Neuropathol       Date:  2021-01-04       Impact factor: 17.088

4.  Respiration Enhances TDP-43 Toxicity, but TDP-43 Retains Some Toxicity in the Absence of Respiration.

Authors:  Sei-Kyoung Park; Sangeun Park; Susan W Liebman
Journal:  J Mol Biol       Date:  2019-03-21       Impact factor: 5.469

Review 5.  Pathomechanisms of TDP-43 in neurodegeneration.

Authors:  Ju Gao; Luwen Wang; Mikayla L Huntley; George Perry; Xinglong Wang
Journal:  J Neurochem       Date:  2018-02-27       Impact factor: 5.372

6.  TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.

Authors:  Ju Gao; Luwen Wang; Chao Gao; Hiroyuki Arakawa; George Perry; Xinglong Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-10-31       Impact factor: 5.187

Review 7.  Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.

Authors:  Alistair Wood; Yuval Gurfinkel; Nicole Polain; Wesley Lamont; Sarah Lyn Rea
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

8.  Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function.

Authors:  Michael Briese; Lena Saal-Bauernschubert; Patrick Lüningschrör; Mehri Moradi; Benjamin Dombert; Verena Surrey; Silke Appenzeller; Chunchu Deng; Sibylle Jablonka; Michael Sendtner
Journal:  Acta Neuropathol Commun       Date:  2020-07-24       Impact factor: 7.801

Review 9.  Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship.

Authors:  Niccolò Candelise; Illari Salvatori; Silvia Scaricamazza; Valentina Nesci; Henri Zenuni; Alberto Ferri; Cristiana Valle
Journal:  Metabolites       Date:  2022-03-09

Review 10.  Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases.

Authors:  Hibiki Kawamata; Giovanni Manfredi
Journal:  J Cell Biol       Date:  2017-11-22       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.